Research into next generation, game-changing medicine is at record highs, but many promising drugs in trials fail and that can make picking winning investments tough. Rather than investing in the drugmakers creating new medicine, a better approach may be to invest in companies that are helping them along the way. Here are three companies that make their money from helping biopharma companies research, develop, and market their next medicine.
